US Stock
Closed Market
Ascendis Pharma Stock
•ASNDClosed Market
$229,63
+$2,13(0,94%)Past Day
+$2,13(0,94%)After Hours
About Ascendis Pharma
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. The firm produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system dis Read moreSectorHealth Care
IndustryPharmaceuticals, Biotechnology & Life Sciences
ExchangeNASDAQ NMS - GLOBAL MARKET
Employees1,017
HeadquarterHellerup, United States
Websiteascendispharma.dk
SymbolASND
Key Statistics
General
Valuation Ratios
Profitability
Market Cap0
Dividend Yield$0
Avg. Volume0
Earnings per Share$0
Enterprise Value (EV)$0
52w High$0 (Invalid Date)
52w Low$0 (Invalid Date)
1Y Drawdown0%
EBITDA$0
PEG Ratio0,00
People Also Bought
USO$116,24
+7,58%
BMBL$3,83
+34,86%
OXY$58,65
+5,52%
DOW$37,20
+8,23%
CF$136,32
+13,48%
XPEV$20,37
+5,57%
NTR$84,70
+6,80%
LYB$72,46
+7,56%
KR$75,72
+4,88%
ACI$17,14
+4,26%
PSX$176,99
+4,42%
ICL$5,47
+4,69%
SAVA$2,38
+12,26%
AWK$139,72
+4,00%
APD$289,53
+4,26%
USO$116,24
+7,58%
BMBL$3,83
+34,86%
OXY$58,65
+5,52%
DOW$37,20
+8,23%
CF$136,32
+13,48%
XPEV$20,37
+5,57%
NTR$84,70
+6,80%
LYB$72,46
+7,56%
KR$75,72
+4,88%
ACI$17,14
+4,26%
PSX$176,99
+4,42%
ICL$5,47
+4,69%
SAVA$2,38
+12,26%
AWK$139,72
+4,00%
APD$289,53
+4,26%
